https://www.selleckchem.com/pr....oducts/tubastatin-a.
ions of Asia, implementation trials are needed to inform evidence-based design of strategies for this vulnerable population.BACKGROUND Community-acquired pneumonia (CAP) is one of the leading worldwide causes of childhood morbidity and mortality. Its disease burden varies by age and etiology and is time dependent. We aimed to investigate the annual and seasonal patterns in etiologies of pediatric CAP requiring hospitalization. METHODS We conducted a retrospective study in 30,994 children (aged 0-18 years) with CAP between 2010 and
Like
Comment
Share
